Showing results (341-350 of 362) with videos related to
Sort By:
Pageof 37
Annals of the American Thoracic Society|December 18, 2023
Validation of Constant Work Rate Cycling Endurance Time for Use in Chronic Obstructive Pulmonary Disease Clinical TrialsRichard Casaburi, Debora Merrill, Nancy Kline Leidy, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|July 31, 2020
Effects of elevated positive end-expiratory pressure on diaphragmatic blood flow and vascular resistance during mechanical ventilationAndrew G Horn, Dryden R Baumfalk, Kiana M Schulze, et al.Microvascular Research|April 13, 2024
Pulmonary hypertension impairs vasomotor function in rat diaphragm arteriolesKiana M Schulze, Andrew G Horn, Judy M Muller-Delp, et al.JACC. Basic to Translational Science|March 28, 2020
Peripheral Determinants of Oxygen Utilization in Heart Failure With Preserved Ejection Fraction: Central Role of AdiposityPayman Zamani, Elizabeth A Proto, Jeremy A Mazurek, et al.Journal of Cardiovascular Pharmacology and Therapeutics|August 15, 2015
Skeletal Muscle Vascular Control During Exercise: Impact of Nitrite Infusion During Nitric Oxide Synthase Inhibition in Healthy RatsScott K Ferguson, Angela A Glean, Clark T Holdsworth, et al.Experimental Physiology|June 20, 2025
Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fractionRamona E Weber, Kiana M Schulze, Andrew G Horn, et al.Circulation|December 24, 2014
Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fractionPayman Zamani, Deepa Rawat, Prithvi Shiva-Kumar, et al.The European Respiratory Journal|July 3, 2025
Interstitial Lung Abnormalities, Coronary Heart Disease, and MortalityClaire C Cutting, Jonathan A Rose, Ann-Marcia C Tukpah, et al.Chest|November 17, 2021
Longitudinal Association Between Muscle Loss and Mortality in Ever SmokersStefanie E Mason, Rafael Moreta-Martinez, Wassim W Labaki, et al.BMC Musculoskeletal Disorders|January 18, 2011
Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animalsRichard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.Pageof 37